跳至主要内容
临床试验/EUCTR2008-007319-33-GB
EUCTR2008-007319-33-GB进行中(未招募)不适用

Do genes predict response to treatment in age-related macular degeneration? - ARMD pharmacogenetics

eeds Teaching Hospitals NHS Trust0 个研究点开始时间: 2010年11月23日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • Written informed consent
  • Age over 65 years
  • Choroidal neovascularisation secondary to Age-related macular degeneration (ARMD)
  • Lesion size less than 5400 microns
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Lack of informed consent
  • Lesion size greater than 5400 microns at baseline
  • Other ocular pathology likely to influence visual acuity after treatment

研究者

发起方
eeds Teaching Hospitals NHS Trust

相似试验